These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31901549)

  • 21. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.
    Samarakoon R; Overstreet JM; Higgins SP; Higgins PJ
    Cell Tissue Res; 2012 Jan; 347(1):117-28. PubMed ID: 21638209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
    Zhang S; Liu Q; Xiao J; Lei J; Liu Y; Xu H; Hong Z
    Int Immunopharmacol; 2016 May; 34():32-36. PubMed ID: 26919280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.
    Li R; Wang Y; Liu Y; Chen Q; Fu W; Wang H; Cai H; Peng W; Zhang X
    PLoS One; 2013; 8(3):e58848. PubMed ID: 23544048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
    Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
    Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synovial and pulmonary dysfunctions are induced by crosstalk of Smad and Erk pathways in an arthritis model.
    Lei W; Jian L; Chuanbing H; Xi C; Lei L; Tianyang L; Yao G; Haixia F; Lei Z; Zhneg L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):15-22. PubMed ID: 32415922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy.
    Xi W; Zhao X; Wu M; Jia W; Li H
    Cell Biol Int; 2018 Nov; 42(11):1523-1532. PubMed ID: 30080287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction.
    Gairola S; Ram C; Syed AM; Doye P; Kulhari U; Mugale MN; Murty US; Sahu BD
    Eur J Pharmacol; 2021 Nov; 910():174479. PubMed ID: 34480883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A.
    Li L; Luo R; Yang Y; Cheng Y; Ge S; Xu G
    Ren Fail; 2020 Nov; 42(1):1173-1183. PubMed ID: 33213229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
    Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
    J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis.
    XIN BM; WANG XX; JIN W; YAN HM; CUI B; ZHANG XW; HUA F; YANG HZ; HU ZW
    Acta Pharmacol Sin; 2010 Dec; 31(12):1583-92. PubMed ID: 21113175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
    Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
    Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.
    Inazaki K; Kanamaru Y; Kojima Y; Sueyoshi N; Okumura K; Kaneko K; Yamashiro Y; Ogawa H; Nakao A
    Kidney Int; 2004 Aug; 66(2):597-604. PubMed ID: 15253712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
    Lu S; Fan HW; Li K; Fan XD
    Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways.
    Geng XQ; Ma A; He JZ; Wang L; Jia YL; Shao GY; Li M; Zhou H; Lin SQ; Ran JH; Yang BX
    Acta Pharmacol Sin; 2020 May; 41(5):670-677. PubMed ID: 31804606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
    Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
    FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.